TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33740394

Group type: EXPERIMENTAL
Intervention: Valganciclovir 900 mg daily
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Valganciclovir
Number of subjects: 31
Study: 35834252

Group type: EXPERIMENTAL
Intervention: mAb treatment (casirivimab-imdevimab or sotrovimab)
Number of subjects: 3069

Group type: EXPERIMENTAL
Intervention: casirivimab-imdevimab
Number of subjects: 3069

Group type: EXPERIMENTAL
Intervention: sotrovimab
Number of subjects: 3069
Study: 33046611

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT)
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: White matter lesions (WML) severity
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Interaction of treatment allocation and WML severity
Number of subjects: 473
Study: 33403334

Group type: EXPERIMENTAL
Intervention: Neoniti A1 (#25) single file
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: RaCe #25/.06 single file
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Mtwo #25/.06 single file
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Easy RaCe
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Mtwo multifile
Number of subjects: 105
Study: 35896211

Group type: EXPERIMENTAL
Intervention: Oral imatinib
Number of subjects: 385

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 385
Study: 33736663

Group type: EXPERIMENTAL
Intervention: Energy availability (EA) measured at 29.5 kcal/kg FFM/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cognitive restraint (≥13)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Performance tests (endurance, agility, explosive strength)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cognitive restraint
Number of subjects: 12
Study: 32185203

Group type: EXPERIMENTAL
Intervention: HA-coated implants
Number of subjects: 52

Group type: COMPARATOR
Intervention: non-HA-coated implants
Number of subjects: 52
Study: 34269640

Group type: EXPERIMENTAL
Intervention: Brief group transdiagnostic psychotherapy (Unified Protocol)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Treatment as usual (medication)
Number of subjects: 105
Study: 34090368

Group type: EXPERIMENTAL
Intervention: EDDIE program (multi-component intervention)
Number of subjects: 12
Study: 616357430

Group type: EXPERIMENTAL
Intervention: Higher MOSSS‐6 scores in men without BPH at baseline
Number of subjects: 2588

Group type: EXPERIMENTAL
Intervention: Higher MOSSS‐6 scores in men with BPH at baseline
Number of subjects: 2588
Study: 36056389

Group type: EXPERIMENTAL
Intervention: CBL-PBL teaching methods
Number of subjects: 4

Group type: COMPARATOR
Intervention: Traditional teaching method
Number of subjects: 4
Study: 34912506

Group type: EXPERIMENTAL
Intervention: 200 mL/day low-fat milk
Number of subjects: 60

Group type: COMPARATOR
Intervention: 30 g/day pistachio
Number of subjects: 60
Study: 35230600

Group type: EXPERIMENTAL
Intervention: Supervisor Audit and Feedback (SAF) intervention
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Observational coding system
Number of subjects: 60
Study: 33131328

Group type: EXPERIMENTAL
Intervention: Aerobic exercise with an arm crank ergometer (15 sessions, 30 minutes/day) at an intensity of 64% to 76% of maximum heart rate, in addition to conventional inpatient rehabilitation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Aerobic exercise with an arm crank ergometer
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional inpatient rehabilitation
Number of subjects: 40
Study: 33741297

Group type: EXPERIMENTAL
Intervention: Silodosin (3 days preoperatively)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (no silodosin premedication)
Number of subjects: 100
Study: 32066608

Group type: EXPERIMENTAL
Intervention: Percutaneous needle electrolysis combined with eccentric exercise
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Dry needling combined with eccentric exercise
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo needling combined with eccentric exercise
Number of subjects: 57
Study: 34229299

Group type: EXPERIMENTAL
Intervention: Differentially expressed genes (DEGs) identified in bone metastatic CRPC tumors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Core genes involved in regulation of extracellular matrix receptor interaction and chemotactic activity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immune infiltration analysis of CD4+ T cells
Number of subjects: 0
Study: 35098820

Group type: EXPERIMENTAL
Intervention: High-dose amoxicillin-proton pump inhibitor dual therapy (20 mg esomeprazole four times daily and 750 mg amoxicillin four times daily for 14 days)
Number of subjects: 971

Group type: COMPARATOR
Intervention: Bismuth-containing quadruple therapy (220 mg bismuth potassium citrate twice daily, 20 mg esomeprazole twice daily, 1000 mg amoxicillin twice daily, and 250 mg clarithromycin capsule twice daily for 14 days)
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: High-dose amoxicillin-proton pump inhibitor dual therapy
Number of subjects: 971
Study: 33421972

Group type: COMPARATOR
Intervention: Simulator training (Group 1)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cadaver training (Group 2)
Number of subjects: 34
Study: 33902701

Group type: EXPERIMENTAL
Intervention: Guided online cognitive behavioral therapy for insomnia (i-Sleep)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Waiting-list control condition
Number of subjects: 70
Study: 33272333

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 international units) administered daily for 5 days
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 international units) administered every other day for 5 days
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 international units) administered as a single dose
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Oxytocin effects on resting-state functional connectivity
Number of subjects: 150
Study: 33837458

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression therapy (IPCT) with compression garment (CG) for 45 min, 3 times a week, for 4 weeks.
Number of subjects: 43

Group type: COMPARATOR
Intervention: Compression garment (CG) for 24 h, through 4 weeks.
Number of subjects: 43
Study: 35229752

Group type: EXPERIMENTAL
Intervention: Carbohydrate mouth rinsing (CMR) with 6.6% maltodextrin
Number of subjects: 13

Group type: COMPARATOR
Intervention: Mineral water (control)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Carbohydrate mouth rinsing (CMR)
Number of subjects: 13
Study: 36327426

Group type: EXPERIMENTAL
Intervention: Durvalumab plus chemotherapy (D + CT)
Number of subjects: 1013

Group type: EXPERIMENTAL
Intervention: Tremelimumab plus durvalumab and chemotherapy (T + D + CT)
Number of subjects: 1013

Group type: COMPARATOR
Intervention: Chemotherapy alone (CT)
Number of subjects: 1013
Study: 33602211

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) scrubbing (test group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ultrasonic cleaning with CHX solution, acetone, and ethyl alcohol (test group 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Steam cleaning (control group)
Number of subjects: 30
Study: 32211803

Group type: EXPERIMENTAL
Intervention: HFCM containing 6 g spice blend
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: HFCM containing 2 g spice blend
Number of subjects: 12

Group type: COMPARATOR
Intervention: HFCM with 0 g spice blend
Number of subjects: 12

Group type: COMPARATOR
Intervention: HFCM
Number of subjects: 12
Study: 35535151

Group type: EXPERIMENTAL
Intervention: Qibin Tongbian decoction
Number of subjects: 62
Study: 34476776

Group type: EXPERIMENTAL
Intervention: Cardiac shock wave therapy (CSWT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (pseudo-treatment)
Number of subjects: 30
Study: 33852655

Group type: EXPERIMENTAL
Intervention: Inferomedial wall orbital decompression (IM-OD)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Balanced medial plus lateral wall orbital decompression (ML-OD)
Number of subjects: 42
Study: 35123497

Group type: EXPERIMENTAL
Intervention: Indoor light visible from outside the hut
Number of subjects: 300

Group type: COMPARATOR
Intervention: Closed eaves huts
Number of subjects: 300

Group type: COMPARATOR
Intervention: Well-ventilated huts
Number of subjects: 300
Study: 34478870

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) consisting of eight weekly therapist-led, two-hour group sessions, and home practice (≥30 min/day, 6 days/week) during the 12-month study.
Number of subjects: 766

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Therapy (MBT) consisting of eight weekly therapist-led, two-hour group sessions, and home practice (≥30 min/day, 6 days/week) during the 12-month study.
Number of subjects: 766

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 766

Group type: COMPARATOR
Intervention: Mindfulness-Based Therapy (MBT)
Number of subjects: 766
Study: 33398614

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) - transdermal: 980 nm, 200 mW, continuous, average energy fluency of 6 J/cm2 and intravenous: 405 nm, 1.5 mW, continuous for 30 min, applied before and after surgery for 6 days.
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Standard treatment only
Number of subjects: 192
Study: 35882620

Group type: EXPERIMENTAL
Intervention: Concomitant durvalumab with standard chemo/radiation followed by 1 year of consolidative durvalumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard chemo/radiation followed by 1 year of consolidative durvalumab
Number of subjects: 0
Study: 34753431

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral training (4 sessions of individual counseling)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Routine pregnancy visits (control group)
Number of subjects: 92
Study: 32868311

Group type: COMPARATOR
Intervention: High carbohydrate + low GI (Cg)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Low carbohydrate + high GI (cG)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Low carbohydrate + low GI (cg)
Number of subjects: 163
Study: 33970869

Group type: EXPERIMENTAL
Intervention: Norgestrel 75 mcg taken daily
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Norgestrel 75 mcg taken 6 hours late
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Norgestrel 75 mcg missed pill
Number of subjects: 52
Study: 32083653

Group type: EXPERIMENTAL
Intervention: Fibre-optic confocal microscopy (FCM) using fluorescein sodium dye
Number of subjects: 6
Study: 35901043

Group type: EXPERIMENTAL
Intervention: Modified version of the Respecting Choices' advance care planning programme
Number of subjects: 28
Study: 33823967

Group type: EXPERIMENTAL
Intervention: Online Responsible Vendor Training (RMV)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Usual and customary training (Control)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Online Responsible Vendor Training (RMV) in Washington State
Number of subjects: 175

Group type: COMPARATOR
Intervention: Usual and customary training (Control) in Washington State
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Online Responsible Vendor Training (RMV) in Colorado
Number of subjects: 175

Group type: COMPARATOR
Intervention: Usual and customary training (Control) in Colorado
Number of subjects: 175
Study: 36855010

Group type: EXPERIMENTAL
Intervention: MLE-based blend (2-g blend of 250 mg MLE, 1.75 g fiber, 0.75 μg vitamin D3, 75 μg chromium)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Blend without MLE (control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MLE-based blend
Number of subjects: 30
Study: 33074192

Group type: EXPERIMENTAL
Intervention: Subthalamic stimulation (STN-DBS)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Standard-of-care medical therapy (MED)
Number of subjects: 159
Study: 34925217

Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES) with conventional therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo electrical stimulation (NMESsham) with conventional therapy
Number of subjects: 44
Study: 34324504

Group type: EXPERIMENTAL
Intervention: Prompt emphasizing government efforts to ensure data privacy
Number of subjects: 23000

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 23000
Study: 32318813

Group type: EXPERIMENTAL
Intervention: LLLT + BFR
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: BFR
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control
Number of subjects: 15
Study: 36441678

Group type: EXPERIMENTAL
Intervention: Educational intervention (2-hour session in a one-day TB educational intervention course)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group (received the same educational materials after the RCT)
Number of subjects: 146
Study: 33886568

Group type: EXPERIMENTAL
Intervention: 25 mg oxazepam
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal task
Number of subjects: 33
Study: 33458939

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy with completion of frequency volume charts regularly
Number of subjects: 100

Group type: COMPARATOR
Intervention: Frequency volume charts regularly alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy with completion of frequency volume charts regularly (after excluding 6 patients with <50% achievement)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Frequency volume charts regularly alone (after excluding 6 patients with <50% achievement)
Number of subjects: 100
Study: 32828135

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) plus standard care
Number of subjects: 194

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 194
Study: 33369223

Group type: EXPERIMENTAL
Intervention: NTI-tss device
Number of subjects: 10

Group type: COMPARATOR
Intervention: Michigan splint
Number of subjects: 10
Study: 34919827

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (PORT) at a dose of 54 Gy in 27 or 30 daily fractions, on five consecutive days a week.
Number of subjects: 501

Group type: COMPARATOR
Intervention: No postoperative radiotherapy (control group).
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (PORT)
Number of subjects: 501
Study: 34170904

Group type: EXPERIMENTAL
Intervention: Integrated package of continuum of care (CoC) interventions including CoC card, CoC orientation for health workers, and 24-hour stay at a health facility or home visit within 48 hours after delivery.
Number of subjects: 2970

Group type: EXPERIMENTAL
Intervention: Integrated package of continuum of care (CoC) interventions.
Number of subjects: 2970

Group type: COMPARATOR
Intervention: Control arm (routine services only).
Number of subjects: 2970
Study: 33132658

Group type: EXPERIMENTAL
Intervention: Cap-assisted colonoscopy (CC)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Regular colonoscopy (RC)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Cap-assisted colonoscopy (CC) in patients with constipation
Number of subjects: 331

Group type: COMPARATOR
Intervention: Regular colonoscopy (RC) in patients with constipation
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Cap-assisted colonoscopy (CC) in ulcerative colitis patients
Number of subjects: 331

Group type: COMPARATOR
Intervention: Regular colonoscopy (RC) in ulcerative colitis patients
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Cap-assisted colonoscopy (CC) during unsedated colonoscopy
Number of subjects: 331

Group type: COMPARATOR
Intervention: Regular colonoscopy (RC) during unsedated colonoscopy
Number of subjects: 331
Study: 36265810

Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard American diet
Number of subjects: 112
Study: 33870426

Group type: EXPERIMENTAL
Intervention: Oral feeding
Number of subjects: 15

Group type: COMPARATOR
Intervention: G-tube feeding
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: RYGB surgery
Number of subjects: 15
Study: 32416780

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus platinum-based chemotherapy (group A)
Number of subjects: 1213

Group type: COMPARATOR
Intervention: Placebo plus platinum-based chemotherapy (group C)
Number of subjects: 1213

Group type: EXPERIMENTAL
Intervention: Atezolizumab monotherapy (group B)
Number of subjects: 1213
Study: 35660486

Group type: EXPERIMENTAL
Intervention: PePS plus standard care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 34818575

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C (100 mg/kg body weight/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo infusions
Number of subjects: 40
Study: 32316758

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training programme (Training Group, n=50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual rehabilitation procedures (Control Group, n=50)
Number of subjects: 100
Study: 35345521

Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Artificial Neural Network (ANN) model
Number of subjects: 155

Group type: COMPARATOR
Intervention: Logistic regression model and ANN model
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Serum IFN‐γ, MIG, and IP‐10 levels
Number of subjects: 155
Study: 34101779

Group type: EXPERIMENTAL
Intervention: Intranasal insulin (20 IU Humulin R U‐100 b.i.d.) for 12 months
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo (twice daily) for 12 months
Number of subjects: 49
Study: 35524444

Group type: EXPERIMENTAL
Intervention: Bumetanide as an adjunctive treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32336695

Group type: EXPERIMENTAL
Intervention: Probucol 500 mg/day added to lipid-lowering therapy
Number of subjects: 876

Group type: COMPARATOR
Intervention: Lipid-lowering agents (control group)
Number of subjects: 876
Study: 33472992

Group type: EXPERIMENTAL
Intervention: VasoStat (VS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: TR Band (TR)
Number of subjects: 40
Study: 32086915

Group type: EXPERIMENTAL
Intervention: Tympanic injection of dexamethasone
Number of subjects: 242

Group type: COMPARATOR
Intervention: Systemic administration group
Number of subjects: 242
Study: 35677027

Group type: EXPERIMENTAL
Intervention: Quality nursing services
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional nursing services
Number of subjects: 72
Study: 33545387

Group type: COMPARATOR
Intervention: Prophylactic cranial irradiation (PCI)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Hippocampus avoidance PCI (HA‐PCI)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Overall survival
Number of subjects: 168

Group type: COMPARATOR
Intervention: Cumulative incidence of brain metastases at 2 years for PCI
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Cumulative incidence of brain metastases at 2 years for HA‐PCI
Number of subjects: 168
Study: 33380482

Group type: EXPERIMENTAL
Intervention: Guided relaxation-based virtual reality (VR-GR)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Distraction-based virtual reality (VR-D)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 360 video (passive control)
Number of subjects: 90
Study: 35224810

Group type: EXPERIMENTAL
Intervention: Digital cognitive behavioural therapy for insomnia (dCBT-I)
Number of subjects: 1721

Group type: COMPARATOR
Intervention: Patient education
Number of subjects: 1721
Study: 32046499

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation app (Headspace) for 3 months
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation app (Headspace)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation app (Headspace) provided in semester 1
Number of subjects: 250

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 250
Study: 35749950

Group type: EXPERIMENTAL
Intervention: LED phototherapy (AsGaAl, λ850 ± 10 nm, 150 mW, 17 J/cm2, 57 s per session)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Laser phototherapy (AsGaAl, λ780 nm, 70 mW, 20.0 J/cm2, 240 s per session)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non‐irradiated Control
Number of subjects: 60
Study: 32529934

Group type: EXPERIMENTAL
Intervention: Phototherapeutic keratectomy (PTK)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Phototherapeutic keratectomy (PTK) for macular dystrophy
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Phototherapeutic keratectomy (PTK) for granular dystrophy
Number of subjects: 63
Study: 36442441

Group type: EXPERIMENTAL
Intervention: PA-Only
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PA+Cannabis
Number of subjects: 60

Group type: COMPARATOR
Intervention: Attention-Control
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All intervention groups
Number of subjects: 60
Study: 33948969

Group type: EXPERIMENTAL
Intervention: RCC-A
Number of subjects: 51

Group type: COMPARATOR
Intervention: RCC-B
Number of subjects: 51
Study: 32605492

Group type: EXPERIMENTAL
Intervention: Nurse-led care program based on Johnson's behavioral system model for 2 weeks
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 150
Study: 35780089

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 42

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 42
Study: 33608144

Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg/day
Number of subjects: 15
Study: 32679045

Group type: EXPERIMENTAL
Intervention: Intracervical anesthesia
Number of subjects: 300

Group type: COMPARATOR
Intervention: No intracervical anesthesia (Control)
Number of subjects: 300
Study: 36260947

Group type: EXPERIMENTAL
Intervention: Premature Infant Oral Motor Intervention (PIOMI) for 5 min/day for 14 days
Number of subjects: 60
Study: 33298388

Group type: EXPERIMENTAL
Intervention: Rotary instruments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 0
Study: 35075765

Group type: EXPERIMENTAL
Intervention: 2 g of amoxicillin
Number of subjects: 474

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 474
Study: 33888404

Group type: EXPERIMENTAL
Intervention: Long-axis, syringe-free in-plane approach (Group I, n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Short-axis out-of-plane approach (Group II, n = 30)
Number of subjects: 60